Epigenetics in Brain Tumors: HDACs Take Center Stage

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|14|1|48-54

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.14, Iss.1, 2016-01, pp. : 48-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetics in Clinical Management of Children and Adolescents with Brain Tumors

By  

Current Cancer Drug Targets, Vol. 18, Iss. 1, 2017-12 ,pp. : 57-64

Bentham Science Publishers

Access to resources Recommend Favorite

Immunologic Diseases and Brain Tumors

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 3, 2011-06 ,pp. : 192-197

Bentham Science Publishers

Access to resources Recommend Favorite

Ion Transporters in Brain Tumors

By  

Current Medicinal Chemistry, Vol. 22, Iss. 10, 2015-04 ,pp. : 1171-1181

Bentham Science Publishers

Access to resources Recommend Favorite

Patented nanomedicines for the treatment of brain tumors

By Caruso Gerardo   Raudino Giuseppe   Caffo Maria  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 6, 2013-11 ,pp. : 745-754

Future Science

Access to resources Recommend Favorite

Magnetic Nanoparticles for MRI of Brain Tumors

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 12, 2012-09 ,pp. : 2403-2416

Bentham Science Publishers

Access to resources Recommend Favorite